GSK plc
GLAXF
$26.00
$0.532.08%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.99% | -0.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.99% | -0.55% | |||
| Cost of Revenue | -28.85% | 15.28% | |||
| Gross Profit | -4.64% | -6.17% | |||
| SG&A Expenses | -22.25% | 21.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -40.88% | 16.23% | |||
| Total Operating Expenses | -30.83% | 26.10% | |||
| Operating Income | 68.73% | -47.80% | |||
| Income Before Tax | 124.37% | -61.85% | |||
| Income Tax Expenses | 35.98% | -29.50% | |||
| Earnings from Continuing Operations | 151.49% | -66.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -11.44% | 31.48% | |||
| Net Income | 171.53% | -68.84% | |||
| EBIT | 68.73% | -47.80% | |||
| EBITDA | 19.46% | -30.57% | |||
| EPS Basic | 171.21% | -68.72% | |||
| Normalized Basic EPS | 82.66% | -51.67% | |||
| EPS Diluted | 172.26% | -68.75% | |||
| Normalized Diluted EPS | 83.36% | -51.65% | |||
| Average Basic Shares Outstanding | 0.10% | -0.37% | |||
| Average Diluted Shares Outstanding | -0.29% | -0.39% | |||
| Dividend Per Share | -6.10% | 10.99% | |||
| Payout Ratio | -0.64% | 2.15% | |||